Heron Therapeuti
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.9% | -2.1% | +0.1% | +1.2% | +5.6% | +1.1% | -1.6% | +7.3% | +2.8% | -3.8% | +2.5% | |
| – | -2.7% | -1.5% | +2.8% | +2.1% | +7.1% | +1.8% | -0.9% | +8.8% | +3.8% | -3.8% | +0.4% | |
| – | -17.7% | -28.7% | -10.1% | +40.0% | +0.2% | -25.3% | -14.3% | +160.8% | -33.5% | -8.8% | -20.7% | |
| – | +3.9% | -11.0% | -5.8% | +5.3% | -16.4% | -14.5% | -19.8% | +36.6% | -16.0% | -4.0% | -4.7% | |
| – | -5.7% | +8.6% | +12.8% | -9.0% | +17.7% | -0.2% | +1.5% | +1.4% | +10.5% | -6.6% | +7.0% | |
| – | +0.2% | +0.9% | +0.9% | +7.2% | +15.7% | +7.1% | +28.2% | -4.0% | +32.4% | -0.2% | -2.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | -1.9% | +1.8% | +1.8% | +2.3% | -1.0% | -1.8% | -9.7% | +3.2% | -1.8% | +3.5% | |
| – | -0.1% | -5.4% | +6.6% | +6.5% | +6.9% | -3.2% | +192.0% | -65.3% | +7.1% | -5.8% | +1.8% | |
| – | +2.5% | +2.0% | +1.8% | +1.7% | -6.5% | -24.6% | +7,618.0% | -99.6% | – | – | – | |
| – | +104.2% | -78.0% | +1,121.7% | -0.4% | +14.9% | +5.3% | -2.4% | -0.2% | -25.2% | -0.3% | +29.8% | |
| – | +0.2% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | – | – | +0.7% | +0.7% | +0.7% | |
| – | – | – | – | – | – | – | – | – | -3.7% | -36.3% | -24.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.7% | +0.6% | +0.7% | +0.3% | +0.2% | +0.2% | +0.3% | +10.6% | -2.1% | +13.8% | +0.4% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.